(Q45828868)

16 December 2017

title

Live recombinant vaccines using genetically engineered vaccinia virus (English)

1 reference

16 December 2017

main subject

Vaccinia virus

object named as

vaccinia virus

1 reference

Paoletti E

1

1 reference

16 December 2017

Perkus ME

series ordinal

2

1 reference

16 December 2017

Piccini A

series ordinal

3

1 reference

16 December 2017

publication date

1 January 1985

1 reference

16 December 2017

published in

Antiviral Research

1 reference

16 December 2017

volume

Suppl 1

1 reference

16 December 2017

page(s)

301-307

1 reference

16 December 2017

Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Vaccinia virus: a selectable eukaryotic cloning and expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2885%2980042-5

7 January 2021

10.1016/S0166-3542(85)80042-5

Identifiers

DOI

0 references

1 reference

16 December 2017